Cargando…
Metabolomics profile in gastrointestinal cancers: Update and future perspectives
Despite recent progress in diagnosis and therapy, gastrointestinal (GI) cancers remain one of the most important causes of death with a poor prognosis due to late diagnosis. Serum tumor markers and detection of occult blood in the stool are the current tests used in the clinic of GI cancers; however...
Autores principales: | Nannini, Giulia, Meoni, Gaia, Amedei, Amedeo, Tenori, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265149/ https://www.ncbi.nlm.nih.gov/pubmed/32523308 http://dx.doi.org/10.3748/wjg.v26.i20.2514 |
Ejemplares similares
-
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps
por: Nannini, Giulia, et al.
Publicado: (2021) -
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy
por: Russo, Edda, et al.
Publicado: (2023) -
Microbiota Transplant and Gynecological Disorders: The Bridge between Present and Future Treatments
por: Martinelli, Serena, et al.
Publicado: (2023) -
High‐Throughput Metabolomics by 1D NMR
por: Vignoli, Alessia, et al.
Publicado: (2018) -
NMR-Based Plasma Metabolomics at Set Intervals in Newborn Dairy Calves with Severe Sepsis
por: Basoglu, Abdullah, et al.
Publicado: (2018)